Evans has made significant contributions to the life sciences industry, notably as the architect of the first electronic drug submission to the Food and Drug Administration (FDA) in 1985. Coming full circle, Evans joins Narrativa at an inflection point for AI in the life sciences after Narrativa recently became the first company to have its AI-generated clinical trial regulatory documentation submitted to and accepted by the FDA.

Throughout his career, Evans has overseen countless electronic regulatory submissions and the development of complex clinical data warehouse systems. His expertise spans information standards, regulatory compliance, and quality governance. Evans joined CDISC after an eight-year tenure at Accenture, where he was the Principal Director, Global Head of Quality Governance and Regulatory Compliance for Accenture Life Sciences. Prior to that, he served as CIO of Octagon Research Solutions, which had been acquired by Accenture. He also previously served as Chair of the CDISC Advisory Council and as a member of the CDISC Board of Directors. Evans’s educational background includes an MS in Biomedical Engineering from Drexel University and a BS in Biology from Ursinus College.